SCHEMBL7008513

SCHEMBL7008513

CCCCc1nccc(C)c1CCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 4/20 0.52
NOS3 P29474 3/20 0.46
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
SKP2 Q13309 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27839140 0.84 NOS2 (0.43) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL7264503 0.82 NOS2 (0.38) NOS2TDP1L3MBTL1CYP3A4CYP2D6
SCHEMBL28572387 0.81 NOS2 (0.44) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL8713669 0.81 NOS2 (0.49) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL23987750 0.80 NOS2 (0.61) NOS2NOS3CYP3A4ALDH1A1KDM4E
SCHEMBL8713672 0.78 NOS2 (0.82) NOS2NOS3SKP2TLR8
SCHEMBL19005863 0.78 NOS2 (0.42) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL28129531 0.78 NOS2 (0.50) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL16280467 0.78 NOS2 (0.50) NOS2NOS3TDP1L3MBTL1CYP3A4
SCHEMBL31278013 0.78 SMPD3 (0.40) NOS2CYP3A4CYP2D6KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268502-A1 O-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2003-01-02 EP disclosed
WO-2001074834-A1 O-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2001-10-11 WO disclosed